CD274 and neoplasm: A high overlap index typically indicates an active tumor antigen-specific immune response, and relevant studies have demonstrated that a high TCR overlap index is strongly associated with favorable prognoses in patients undergoing treatment with immune checkpoint inhibitors, such as PD-1/PD-L1 inhibitors (38).